Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10–45.
Compérat E, Amin MB, Cathomas R, et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet (London, England). 2022;400(10364):1712–21.
Baksh SC, Finley LWS. Metabolic diversity drives cancer cell invasion. Nature. 2022;605(7911):627–8.
Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science (New York, NY). 2020;368(6487):eaaw5473.
Lin J, Liu G, Chen L, Kwok HF, Lin Y. Targeting lactate-related cell cycle activities for cancer therapy. Semin Cancer Biol. 2022;86(Pt 3):1231–43.
Feng Q, Liu Z, Yu X, et al. Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity. Nat Commun. 2022;13(1):4981.
Lee JM, Hammarén HM, Savitski MM, Baek SH. Control of protein stability by post-translational modifications. Nat Commun. 2023;14(1):201.
Zhang D, Tang Z, Huang H, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575–80.
Yu J, Chai P, Xie M, et al. Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021;22(1):85.
Xie B, Lin J, Chen X, et al. CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. Mol Cancer. 2023;22(1):151.
Massari F, Ciccarese C, Santoni M, et al. Metabolic phenotype of bladder cancer. Cancer Treat Rev. 2016;45:46–57.
Lee SJ, Oses-Prieto JA, Kawaguchi R, et al. Hnrnps interacting with mRNA localization motifs define axonal RNA regulons. Mol Cell Proteomics. 2018;17(11):2091–106.
Wang A, Zeng Y, Zhang W, et al. N(6)-methyladenosine-modified SRPK1 promotes aerobic glycolysis of lung adenocarcinoma via PKM splicing. Cell Mol Biol Lett. 2024;29(1):106.
Jiang C, Xu D, Feng H, et al. Hnrnpa1 promotes the metastasis and proliferation of gastric cancer cells through WISP2-guided Wnt/β-catenin signaling pathway. Discov Oncol. 2024;15(1):465.
Wang JM, Liu N, Wei XJ, et al. Regulation of AUF1 alternative splicing by hnRNPA1 and SRSF2 modulate the sensitivity of ovarian cancer cells to cisplatin. Cell Oncol. 2024;47(6):2349–66.
Yang H, Zhu R, Zhao X, et al. Sirtuin-mediated deacetylation of hnRNP A1 suppresses glycolysis and growth in hepatocellular carcinoma. Oncogene. 2019;38(25):4915–31.
Zhu HE, Li T, Shi S, et al. ESCO2 promotes lung adenocarcinoma progression by regulating hnRNPA1 acetylation. Journal of experimental & clinical cancer research : CR. 2021;40(1):64.
Wang T, Ding G, Wang X, et al. Expression of EPB41L2 in Cancer-Associated Fibroblasts: Prognostic Implications for Bladder Cancer and Response to Immunotherapy. Arch Med Res. 2024;55(1):102927.
Chen Z, Zhou L, Liu L, et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020;11(1):5077.
Zong Z, Ren J, Yang B, Zhang L, Zhou F. Emerging roles of lysine lactyltransferases and lactylation. Nat Cell Biol. 2025;27(4):563–74.
Santos-Martins D, Solis-Vasquez L, Tillack AF, et al. Accelerating AutoDock4 with GPUs and gradient-based local search. J Chem Theory Comput. 2021;17(2):1060–73.
Morgan CE, Meagher JL, Levengood JD, et al. The first crystal structure of the UP1 domain of hnRNP A1 bound to RNA reveals a new look for an old RNA binding protein. J Mol Biol. 2015;427(20):3241–57.
Brownell JE, Zhou J, Ranalli T, et al. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell. 1996;84(6):843–51.
Chen Q, Yang B, Liu X, et al. Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents. Theranostics. 2022;12(11):4935–48.
Lee SY, Lee SH, Choi NH, et al. PCAF promotes R-loop resolution via histone acetylation. Nucleic Acids Res. 2024;52(15):8643–60.
David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature. 2010;463(7279):364–8.
Chen M, Zhang J, Manley JL. Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA. Can Res. 2010;70(22):8977–80.
Xia Y, Wang X, Liu Y, et al. PKM2 Is Essential for Bladder Cancer Growth and Maintenance. Can Res. 2022;82(4):571–85.
Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325–37.
Chen J, Huang Z, Chen Y, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10(1):38.
Li H, Sun L, Gao P, Hu H. Lactylation in cancer: current understanding and challenges. Cancer Cell. 2024;42(11):1803–7.
Zhu S, Guo Y, Zhang X, et al. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics. Cancer Lett. 2021;503:240–8.
Ma Q, Zeng Q, Wang K, et al. Acetyltransferase P300 regulates glucose metabolic reprogramming through catalyzing succinylation in lung cancer. Int J Mol Sci. 2024. https://doi.org/10.3390/ijms25021057.
Huang H, Zhang D, Weng Y, et al. The regulatory enzymes and protein substrates for the lysine β-hydroxybutyrylation pathway. Sci Adv. 2021. https://doi.org/10.1126/sciadv.abe2771.
Yang K, Fan M, Wang X, et al. Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis. Cell Death Differ. 2022;29(1):133–46.
Zhang N, Zhang Y, Xu J, et al. Α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure. Cell Res. 2023;33(9):679–98.
Zong Z, Xie F, Wang S, et al. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell. 2024;187(10):2375-92.e33.
Xiong J, He J, Zhu J, et al. Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 2022;82(9):1660-77.e10.
Li N, Pang FX, Zhou YW, et al. Polydatin sensitizes osteosarcoma cells to methotrexate through suppressing the H19/H3K27me3/H3K9me3 mediated folate metabolism regulatory axis. Bioorg Chem. 2025;162:108583.
Zhao Q, Zhang Y, Liu J, et al. Polydatin enhances oxaliplatin-induced cell death by activating NOX5-ROS-mediated DNA damage and ER stress in colon cancer cells. Front Pharmacol. 2024;15:1532695.
Sun K, Zhang X, Shi J, et al. Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. J Clin Invest. 2025. https://doi.org/10.1172/JCI187024.
Liu Y, Liu P, Duan S, et al. CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. Cell Death Differ.2025;32(4):745–62.